Android app on Google Play

JMP Securities Downgrades Optimer Pharmaceuticals (OPTR) to Market Perform

March 1, 2013 8:17 AM EST Send to a Friend
Get Alerts OPTR Hot Sheet
Price: $12.78 --0%

Rating Summary:
    4 Buy, 9 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade OPTR Now!
Join SI Premium – FREE
JMP Securities downgraded Optimer Pharmaceuticals (NASDAQ: OPTR) from Market Outperform to Market Perform.

For an analyst ratings summary and ratings history on Optimer Pharmaceuticals click here. For more ratings news on Optimer Pharmaceuticals click here.

Shares of Optimer Pharmaceuticals closed at $12.12 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

JMP Securities

Add Your Comment